MNCs Bolstering China Presence Despite Slowdown
This article was originally published in PharmAsia News
Executive Summary
Despite a general economic and pharma market slowdown in China, several pharmaceutical multinationals have recently unveiled a slew of investments to expand their presence and secure sustainable growth in the country, where the underlying factors for the health care sector are seen remaining strong.